Cannara Biotech8CB0 
$0.50-2.02%24h
-2.02%24h
Global rank23791
Market cap$45.09M
Change 7d-0.41%
YTD Performance-
SP500 benchmark
P/E6.31
P/S1.14
Revenue$39.72M
Earnings$4.82M
Dividend yield-
Main Sector
Healthcare
Cannara Biotech 8CB0 Total Debt
8CB0 Total Debt in 2022: $27.56M
According to Cannara Biotech latest financial reports the total debt is $27.56M, an decrease of -13.99% to 2022. At the end of 2022 company had $32.05M total debt. This figure represents the debts and financial obligations that Cannara Biotech combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Cannara Biotech 8CB0 Total Debt History from 2023 to 2022
-
Value:-
8CB0 Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $27.56M | -13.99% |
| 2022 | $32.05M | 126.85% |
| 2021 | $14.13M | 63.94% |
| 2020 | $8.62M | -5.05% |
| 2019 | $9.08M | - |
View the Top Total Debt Stocks 
